Kathleen M. Bone, PhD

Publications

• Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcoma.

  (Rademacher MJ, Faber ML, Bone KM, Medin JA, Schloemer NJ.) Exp Mol Pathol. 2024 Jun;137:104898 PMID: 38729059 SCOPUS ID: 2-s2.0-85192295267 05/11/2024

• Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells.

  (Sasu BJ, Opiteck GJ, Gopalakrishnan S, Kaimal V, Furmanak T, Huang D, Goswami A, He Y, Chen J, Nguyen A, Balakumaran A, Shah NN, Hamadani M, Bone KM, Prashad S, Bowen MA, Pertel T, Embree HD, Gidwani SG, Chang D, Moore A, Leonard M, Amado RG.) Mol Ther. 2023 Mar 01;31(3):676-685 PMID: 36518079 PMCID: PMC10014221 SCOPUS ID: 2-s2.0-85145741279 12/16/2022

• Chapter: Ring Chromosome 4.

  (Bone, KM, Chernos, J, Thomas, MA.) Human Ring Chromosomes: A practical guide for clinicians and families. Part II Constitutional Ring Chromosomes.. In review. 03/30/2023

• Atypical Presentation in Sclerosing Epithelioid Fibrosarcoma: A Case Report

  (Miller LJ, Saterbak A, Parsons LN, Singh R, Bone KM..) AJCP. 9 Nov 2022; 158 (Supplement_1):S38-S39:doi: 10.1093/ajcp/aqac126.072 11/09/2022

• Effects of EWSR1 Amplification on the Clinical and Histologic Behavior of Non-Ewing Sarcoma Soft Tissue Tumors

  (Miller LJ, Bodnar C, Parsons LN, Singh R, Bone KM..) JMD [Internet]. 2022 Oct. 24(10, Supplement) S1-S154.doi: 10.1016/S1525-1578(22)00284-7 10/24/2022

• Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation.

  (Scheuermann A, Moskop A, Hopp A, Bone K, Drendel HM, Talano J, Harker-Murray P, Astle J.) J Pediatr Hematol Oncol. 2022 Jul 01;44(5):268-270 PMID: 35235548 SCOPUS ID: 2-s2.0-85129146818 03/03/2022

• It Takes a Village: Providing International Pediatric Pathology Services in a Resource-Limited Setting.

  (Hopp AM, Tetzlaff JE, Kopidlansky K, Leventaki V, Parsons LN, Bone K, Drendel HM, Sreynich K, Lyvannak S, Heng S, Chanpheaktra N, Putchhat H, Khauv P, Camitta BM, Jarzembowski JA.) Am J Clin Pathol. 2022 Jul 01;158(1):81-95 PMID: 35050350 SCOPUS ID: 2-s2.0-85133980519 01/21/2022

• Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958.

  (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P.) Cancers (Basel). 2022 May 16;14(10) PMID: 35626175 PMCID: PMC9140135 05/29/2022

• Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P.

  (Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance.) Cancers (Basel). 2022 May 16;14(10):2443. PMCID: PMC9140135 05/16/2022

• A complex KMT2A::AFF3 fusion resulting from a three-way chromosomal rearrangement in pediatric B lymphoblastic leukemia.

  (Miller LJ, Leventaki V, Harker-Murray PD, Drendel HM, Bone KM.) Cancer Genet. 2022 Apr;262-263:43-46 PMID: 34995897 SCOPUS ID: 2-s2.0-85122276846 01/08/2022

• Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance.

  (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P.) Cancers (Basel). 2022 Feb 15;14(4) PMID: 35205706 PMCID: PMC8870411 02/26/2022

• Fine-needle aspiration diagnosis of clonal extramedullary hematopoiesis in a case of myeloproliferative neoplasm.

  (Shponka V, Bone K, Nomani L, Hunt B.) Diagn Cytopathol. 2022 Feb;50(2):E43-E46 PMID: 34617678 SCOPUS ID: 2-s2.0-85116487437 10/08/2021